How did HLVX's expenses impact its Q4 2024 revenue?
5/9/2025 09:16am
HilleVax's (HLVX) expenses had a significant negative impact on its revenue in Q4 2024, resulting in a net loss of $33.95 million for the period. The company's total expenses far exceeded its reported revenue, indicating a challenging financial period for HLVX.
|code|Ticker|Name|Date|R&D Expenses|Total Revenue|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|HLVX|HLVX.O|HilleVax|2024 Q1|4.1303E7||-4.6829E7|185|
|HLVX|HLVX.O|HilleVax|2024 Q2|2.6601E7||-4.0668E7|185|
|HLVX|HLVX.O|HilleVax|2024 Q3|2.0165E7||-2.5823E7|185|
|HLVX|HLVX.O|HilleVax|2024 Q4|5428000||-3.3947E7|185|